Search for Clinical Trial Results

Sponsored By

Hepatitis D - 32 Studies Found

Status Study
Recruiting Study Name: Ezetimibe for Patients With Chronic Hepatitis D
Condition: Chronic Hepatitis D
Date: 2017-03-28
Interventions: Drug: Ezetimibe Ezetimibe 20 mg oral daily
Completed Study Name: Lonafarnib for Chronic Hepatitis D
Condition: Hepatitis D
Date: 2011-12-16
Interventions:
  • Drug: Lonafarnib Commercially

Recruiting Study Name: The Hepatitis Delta International Network
Condition: Hepatitis D
Date: 2015-02-19
Completed Study Name: Pegylated Interferon to Treat Chronic Hepatitis D
Condition: Hepatitis D
Date: 2001-09-03
Interventions: Drug: Peginterferon Alpha-2a Treatment
Active, not recruiting Study Name: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
Condition: Hepatitis D, Chronic
Date: 2017-03-26
Interventions:
  • Drug: Pegylated interferon alfa

Terminated Study Name: Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Condition: Hepatitis D
Date: 2011-03-14
Interventions: Drug: EBP921 Patients randomized to receive low or high dose. All dosing of EBP921 should be taken with
Completed Study Name: Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Date: 2015-07-29
Interventions:
  • Drug: Lonafarnib prenylation i
Completed Study Name: A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Date: 2016-04-05
Interventions: Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2
Completed Study Name: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Date: 2016-04-01
Interventions:
  • Drug: Peginterferon alfa-2a Pe
Terminated Study Name: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis D, Chronic
Date: 2013-05-02
Next >>>